Sequenom's Share Price Doubles in June as Caliper Continues to Sag | GenomeWeb
NEW YORK (GenomeWeb News) – Sequenom’s stock was by far the biggest gainer — more than doubling its price — in June among the 36 companies that comprise the GenomeWeb Daily News Index.
In a tough month for the stock market, in general, Sequenom’s shares rose 107.5 percent. On the other end of the spectrum, shares of Caliper Life Sciences continued to decline, falling 27.6 percent for the month of June.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.